Home  | Publications | HBK+22a

Predicting Single-Cell Perturbation Responses for Unseen Drugs

MCML Authors

Link to Profile Niki Kilbertus PI Matchmaking

Niki Kilbertus

Prof. Dr.

Principal Investigator

Link to Profile Stephan Günnemann PI Matchmaking

Stephan Günnemann

Prof. Dr.

Principal Investigator

Link to Profile Fabian Theis PI Matchmaking

Fabian Theis

Prof. Dr.

Principal Investigator

Abstract

Single-cell transcriptomics enabled the study of cellular heterogeneity in response to perturbations at the resolution of individual cells. However, scaling high-throughput screens (HTSs) to measure cellular responses for many drugs remains a challenge due to technical limitations and, more importantly, the cost of such multiplexed experiments. Thus, transferring information from routinely performed bulk RNA-seq HTS is required to enrich single-cell data meaningfully. We introduce a new encoder-decoder architecture to study the perturbational effects of unseen drugs. We combine the model with a transfer learning scheme and demonstrate how training on existing bulk RNA-seq HTS datasets can improve generalisation performance. Better generalisation reduces the need for extensive and costly screens at single-cell resolution. We envision that our proposed method will facilitate more efficient experiment designs through its ability to generate in-silico hypotheses, ultimately accelerating targeted drug discovery.

inproceedings


MLDD @ICML 2022

Workshop on Machine Learning for Drug Discovery at the 39th International Conference on Machine Learning. Baltimore, MD, USA, Jul 17-23, 2022.

Authors

L. Hetzel • S. Boehm • N. KilbertusS. Günnemann • M. Lotfollahi • F. J. Theis

Links

URL

Research Areas

 A3 | Computational Models

 C2 | Biology

BibTeXKey: HBK+22a

Back to Top